TG2′s activity is indeed linked with the formation of cancer stem cells (CSCs) as it increases, through a non-canonical NF-κB pathway, the expression of CD44, their typical marker and a promoter of immortality, metastasis, chemoresistance, and a stem-like phenotype [44,52]. Here, TGM2 is linked to cancer.